Медицински услуги по домовете за област Варна

12/05/2026

🧠 Fish oil may not always help the brain recover after injury.

A new study suggests that EPA — one of the main omega-3 fatty acids in fish oil — may interfere with repair after repeated mild traumatic brain injury.

In mouse models, long-term fish oil supplementation was linked to poorer neurological and spatial learning performance over time. The researchers also saw weaker blood vessel repair signals and buildup of tau protein around brain blood vessels — a pattern relevant to chronic traumatic encephalopathy, or CTE.

In lab-grown human brain blood vessel cells, EPA, but not DHA, reduced repair capacity under certain metabolic conditions. The team also found related changes in postmortem brain tissue from people with CTE.

This does not mean fish oil is universally harmful. It suggests omega-3 effects may depend on brain state, injury history, and biology.

📃 RESEARCH PAPER
📌 Karakaya et al., “Eicosapentaenoic acid reprograms cerebrovascular metabolism and impairs repair after brain injury, with relevance to chronic traumatic encephalopathy”, Cell Reports (2026)

23/04/2026

🧂 Iodised salt was one of the great public health triumphs of the 20th century. It eliminated goitre across entire continents and raised national IQs. Now, quietly, its gains are being reversed — and the culprit is good taste.

The core problem is aesthetic. Iodised salt has been steadily displaced by shimmering sea salt crystals, Himalayan pink rock salt, smoked flakes, and Kosher salt — while the few remaining packages of iodised salt sit in uninspired, drab packaging, decidedly out of step with contemporary trends. None of these fashionable alternatives contain meaningful iodine. And the people switching to them largely have no idea.

The consequences are showing up in exactly the population that can least afford them. 46 per cent of pregnant women in the US currently exhibit insufficient iodine levels. In Australia, 62 per cent of pregnant and breastfeeding women report insufficient iodine status. The stakes are not abstract: even subtle to moderate iodine deficiency in utero has been estimated to reduce intelligence by as much as 0.3 to 13 IQ points. Goitre, once effectively eradicated across the developed world, is edging back.

"The main message is that iodine deficiency is re-emerging as a public health concern in countries that had previously eliminated it," said one public health expert tracking the trend. The fix remains exactly what it was a century ago — and costs almost nothing to implement.
This is not a story about poverty or neglect. It is a story about wellness culture quietly dismantling a century of public health progress, one artisanal salt grinder at a time.

Source: New Scientist

23/04/2026

🧬 Parkinson's disease affects over 10 million people worldwide, and not a single approved treatment can slow or stop the underlying damage. Every existing drug manages symptoms. None targets the disease itself. A new study, presented at the Oxford Glymphatic and Brain Clearance Symposium, suggests that may be about to change.

Researcher Zhao Yan at Swinburne University of Technology in Melbourne has been investigating whether boosting the brain's glymphatic system, its waste-clearing network active during deep sleep, could remove the toxic protein alpha-synuclein that accumulates in Parkinson's disease and destroys dopamine-producing neurons.

Using a mouse model that replicates Parkinson's more accurately than previous methods by introducing misfolded alpha-synuclein through the nose, Yan's team gave half of 20 affected mice an FDA-approved drug they are calling only "Compound X" for intellectual property reasons. The drug boosts slow brain waves, which drive glymphatic clearance. It was given four times a week from the two-month mark of the four-month study.

The results were dramatic. In a balance and mobility test, 80% of the Compound X mice completed the task successfully, compared to just 10% of controls. In a second test, treated mice balanced on a rotating rod for nearly the full five minutes; controls dropped off around three minutes on average. Further analysis confirmed that Compound X enhanced glymphatic fluid flow and reduced alpha-synuclein accumulation in the brain.

The team hopes to begin trials in people with early-stage Parkinson's within the next year.

📄 RESEARCH PAPER
📌 Yan et al, Swinburne University of Technology — presented at Oxford Glymphatic and Brain Clearance Symposium (April 2026), not yet published in a peer-reviewed journal

23/04/2026

09/04/2026

Неваксинирането на децата трябва да се криминализира и родителите им да носят наказателна отговорност!

24/03/2026

For people with eczema, stress can trigger flare-ups and worsen their itchy rashes. But the link between stress and skin inflammation has been unclear.

Now, researchers have identified a network of neurons that respond to stress by activating immune cells in the skin, fuelling eczema symptoms. http://spklr.io/6003Ey8hP

22/11/2025

Yet, there are many things we don't know about the phenomenon, scientifically speaking, such as, why it exists. Scientists have been pondering this for centuries.

21/11/2025

The Jungle of the Brain: This image shows a fraction of the brain's dense network. It's what you'd see if 99.9% of all cells were removed. In reality, this 'empty' space is packed with countless other neurons connecting to these dendrites, as well as essential glial cells (astrocytes, oligodendrocytes, microglia), and blood vessels. The brain is an incredibly crowded space.